NCT07100964View on ClinicalTrials.gov

A Study in Healthy Men to Test Whether Carbamazepine Influences the Amount of Nerandomilast in the Blood

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 11, 2025

Primary Completion Date

September 20, 2025

Study Completion Date

October 1, 2025

Conditions
Healthy
Interventions
DRUG

nerandomilast

nerandomilast

DRUG

carbamazepine

carbamazepine

Trial Locations (1)

68167

CRS Clinical Research Services Mannheim GmbH, Mannheim

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY